Serial assessment of human tumor burdens in mice by the analysis of circulating DNA

Cancer Research

Volumn 67, Issue 19, 2007, Pages 9364-9370

  Rago, Carlo ^a,b   Huso, David L ^b,c   Diehl, Frank ^a,b   Karim, Baktiar ^c   Liu, Guosheng ^c   Papadopoulos, Nickolas ^a,b   Samuels, Yardena ^a   Velculescu, Victor E ^a   Vogelstein, Bert ^a,b   Kinzler, Kenneth W ^a,b   Diaz Jr , Luis A ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER MODEL; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MICROENVIRONMENT; MONITORING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TUMOR XENOGRAFT; VALIDATION PROCESS;

ANIMALS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA, NEOPLASM; FEMALE; HCT116 CELLS; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 35148841977     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0605     Document Type: Article

References (31)

1. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002;296:1046-9.
2. Hu M, Yao J, Cai L, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005;37:899-905.
3. Fidler IJ, Kim SJ, Langley RR. The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem 2007;101:927-36.
4. Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 1980;40:2281-7.
5. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
6. Kerbel RS. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived - but they can be improved. Cancer Biol Ther 2003;2:S134-9.
7. Garber K. Realistic rodents? Debate grows over new mouse models of cancer. J Natl Cancer Inst 2006;98:1176-8.
8. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2002;2:11-8.
9. Bouvet M, Tsuji K, Yang M, et al. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 2006;66:11293-7.
10. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 1999;260:712-7.
11. Shih IM, Torrance C, Sokoll LJ, et al. Assessing tumors in living animals through measurement of urinary β-human chorionic gonadotropin. Nat Med 2000;6:711-4.
12. Garcia-Olmo DC, Gutierrez-Gonzalez L, Ruiz-Piqueras R, Picazo MG, Garcia-Olmo D. Detection of circulating tumor cells and of tumor DNA in plasma during tumor progression in rats. Cancer Lett 2005;217:115-23.
13. Kim J, Yu W, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998;94:353-62.
14. Zijlstra A, Mellor R, Panzarella G, et al. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res 2002;62:7083-92.
15. Schneider T, Osl F, Friess T, Stockinger H, Scheuer WV. Quantification of human Alu sequences by real-time PCR - an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin Exp Metastasis 2002;19:571-82.
16. Kamat AA, Bischoff FZ, Dang D, et al. Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol Ther 2006;5:1369-74.
17. Samuels Y, Diaz LA, Jr., Schmidt-Kittler O, et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 2005;7:561-73.
18. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74.
19. Prak ET, Kazazian HH, Jr. Mobile elements and the human genome. Nat RevGene t 2000;1:134-44.
20. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-10.
21. Smit AF. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr Opin Genet Dev1999;9:657-6 3.
22. Kent WJ. BLAT - the BLAST-like alignment tool. Genome Res 2002;12:656-64.
23. Bauer TW, Parvizi J, Kobayashi N, et al. Diagnosis of periprosthetic infection: emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty. J Bone Joint Surg Am 2006;88:869-82.
24. Urban C, Gruber F, Kundi M, et al. A systematic and quantitative analysis of PCR template contamination. J Forensic Sci 2000;45:1307-11.
25. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007;1775:181-232.
26. Diehl F, Diaz LA, Jr. Digital quantification of mutant DNA in cancer patients. Curr Opin Oncol 2007;19:36-42.
27. Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A 2005;102:16368-73.
28. Zirvi KA, Najjar TA, Slomiany BL. Sensitivity of human colon tumor metastases to anticancer drugs in athymic (nude) mice. Cancer Lett 1993;72:39-44.
29. Fournie GJ, Courtin JP, Laval F, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995;91:221-7.
30. To EW, Chan KC, Leung SF, et al. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res 2003;9:3254-9.
31. Shinozaki M, O'Day SJ, Kitago M, et al. Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy. Clin Cancer Res 2007;13:2068-74.